Senseonics Holdings (SENS) Shareholder's Equity Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.94% |
| Dec 31, 2025 | 195.10% |
| Sep 30, 2025 | 93.00% |
| Jun 30, 2025 | 81.12% |
| Mar 31, 2025 | 33.76% |
| Dec 31, 2024 | 55.31% |
| Sep 30, 2024 | 59.91% |
| Jun 30, 2024 | 26.03% |
| Mar 31, 2024 | 28.10% |
| Dec 31, 2023 | 31.01% |
| Sep 30, 2023 | 43.43% |
| Jun 30, 2023 | 49.28% |
| Mar 31, 2023 | 49.13% |
| Dec 31, 2022 | 33.22% |
| Sep 30, 2022 | -37.41% |
| Jun 30, 2022 | 1.66% |
| Mar 31, 2022 | -59.21% |
| Dec 31, 2021 | -66.35% |
| Sep 30, 2021 | -76.31% |
| Jun 30, 2021 | -70.51% |
| Mar 31, 2021 | -141.66% |
| Dec 31, 2020 | -179.47% |
| Sep 30, 2020 | -64.63% |
| Jun 30, 2020 | -74.27% |
| Mar 31, 2020 | -42.72% |
| Dec 31, 2019 | -21.04% |
| Sep 30, 2019 | 81.70% |
| Jun 30, 2019 | 1.62% |
| Mar 31, 2019 | 28.71% |
| Dec 31, 2018 | 110.66% |
| Sep 30, 2018 | 1,074.54% |
| Jun 30, 2018 | 1,224.76% |
| Mar 31, 2018 | -1,405.27% |
| Dec 31, 2017 | -2.80% |
| Sep 30, 2017 | 1,052.02% |
| Jun 30, 2017 | 1,093.16% |